These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

354 related articles for article (PubMed ID: 17613711)

  • 1. Human immunodeficiency virus type 1 RNA Levels in different regions of human brain: quantification using real-time reverse transcriptase-polymerase chain reaction.
    Kumar AM; Borodowsky I; Fernandez B; Gonzalez L; Kumar M
    J Neurovirol; 2007 Jun; 13(3):210-24. PubMed ID: 17613711
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human immunodeficiency virus type 1 in the central nervous system leads to decreased dopamine in different regions of postmortem human brains.
    Kumar AM; Fernandez JB; Singer EJ; Commins D; Waldrop-Valverde D; Ownby RL; Kumar M
    J Neurovirol; 2009 May; 15(3):257-74. PubMed ID: 19499455
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship of antiretroviral treatment to postmortem brain tissue viral load in human immunodeficiency virus-infected patients.
    Langford D; Marquie-Beck J; de Almeida S; Lazzaretto D; Letendre S; Grant I; McCutchan JA; Masliah E; Ellis RJ
    J Neurovirol; 2006 Apr; 12(2):100-7. PubMed ID: 16798671
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human immunodeficiency virus infection in the CNS and decreased dopamine availability: relationship with neuropsychological performance.
    Kumar AM; Ownby RL; Waldrop-Valverde D; Fernandez B; Kumar M
    J Neurovirol; 2011 Feb; 17(1):26-40. PubMed ID: 21165787
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of the human immunodeficiency virus regulatory protein tat in CNS tissues.
    Hudson L; Liu J; Nath A; Jones M; Raghavan R; Narayan O; Male D; Everall I
    J Neurovirol; 2000 Apr; 6(2):145-55. PubMed ID: 10822328
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship between human immunodeficiency virus-associated dementia and viral load in cerebrospinal fluid and brain.
    McArthur JC; McClernon DR; Cronin MF; Nance-Sproson TE; Saah AJ; St Clair M; Lanier ER
    Ann Neurol; 1997 Nov; 42(5):689-98. PubMed ID: 9392567
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decreased neurotropism of nef long terminal repeat (nef/LTR)-deleted simian immunodeficiency virus.
    Thompson KA; Kent SJ; Gahan ME; Purcell DF; McLean CA; Preiss S; Dale CJ; Wesselingh SL
    J Neurovirol; 2003 Aug; 9(4):442-51. PubMed ID: 12907389
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neurovirological correlation with HIV-associated neurocognitive disorders and encephalitis in a HAART-era cohort.
    Gelman BB; Lisinicchia JG; Morgello S; Masliah E; Commins D; Achim CL; Fox HS; Kolson DL; Grant I; Singer E; Yiannoutsos CT; Sherman S; Gensler G; Moore DJ; Chen T; Soukup VM
    J Acquir Immune Defic Syndr; 2013 Apr; 62(5):487-95. PubMed ID: 23242157
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Application of transcription mediated amplification and real-time reverse transcription polymerase chain reaction in detection of human immunodeficiency virus RNA].
    Wu D; Tao S; Liu S; Zhou J; Tan D; Hou Z
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2017 Jul; 42(7):776-782. PubMed ID: 28845000
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regional quantitative comparison of multispliced to unspliced ratios of HIV-1 RNA copy number in infected human brain.
    Fujimura RK; Khamis I; Shapshak P; Goodkin K
    J NeuroAIDS; 2004; 2(4):45-60. PubMed ID: 16873205
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Independent evolution of human immunodeficiency virus (HIV) drug resistance mutations in diverse areas of the brain in HIV-infected patients, with and without dementia, on antiretroviral treatment.
    Smit TK; Brew BJ; Tourtellotte W; Morgello S; Gelman BB; Saksena NK
    J Virol; 2004 Sep; 78(18):10133-48. PubMed ID: 15331746
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High level HIV-1 DNA concentrations in brain tissues differentiate patients with post-HAART AIDS dementia complex or cardiovascular disease from those with AIDS.
    Zhao L; Galligan DC; Lamers SL; Yu S; Shagrun L; Salemi M; McGrath MS
    Sci China C Life Sci; 2009 Jul; 52(7):651-6. PubMed ID: 19641870
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reversible dementia in a patient with central nervous system escape of human immunodeficiency virus.
    Bogoch II; Davis BT; Venna N
    J Infect; 2011 Sep; 63(3):236-9. PubMed ID: 21658774
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cerebrospinal fluid HIV-1 RNA levels: correlation with HIV encephalitis.
    Cinque P; Vago L; Ceresa D; Mainini F; Terreni MR; Vagani A; Torri W; Bossolasco S; Lazzarin A
    AIDS; 1998 Mar; 12(4):389-94. PubMed ID: 9520168
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantitative detection of human immunodeficiency virus type 1 (HIV-1) viral load by SYBR green real-time RT-PCR technique in HIV-1 seropositive patients.
    Gibellini D; Vitone F; Gori E; La Placa M; Re MC
    J Virol Methods; 2004 Feb; 115(2):183-9. PubMed ID: 14667534
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transfer and evaluation of an automated, low-cost real-time reverse transcription-PCR test for diagnosis and monitoring of human immunodeficiency virus type 1 infection in a West African resource-limited setting.
    Rouet F; Ekouevi DK; Chaix ML; Burgard M; Inwoley A; Tony TD; Danel C; Anglaret X; Leroy V; Msellati P; Dabis F; Rouzioux C
    J Clin Microbiol; 2005 Jun; 43(6):2709-17. PubMed ID: 15956387
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical evaluation of a low cost, in-house developed real-time RT-PCR human immunodeficiency virus type 1 (HIV-1) quantitation assay for HIV-1 infected patients.
    Kaur P; Khong WX; Wee SY; Tan EL; Pipper J; Koay E; Ng KY; Yap JK; Chew KK; Tan MT; Leo YS; Inoue M; Ng OT
    PLoS One; 2014; 9(3):e89826. PubMed ID: 24603460
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multilevel analysis of neuropathogenesis of neurocognitive impairment in HIV.
    Levine AJ; Soontornniyomkij V; Achim CL; Masliah E; Gelman BB; Sinsheimer JS; Singer EJ; Moore DJ
    J Neurovirol; 2016 Aug; 22(4):431-41. PubMed ID: 26637429
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HIV in the brain: RNA levels and patterns of zidovudine resistance.
    McClernon DR; Lanier R; Gartner S; Feaser P; Pardo CA; St Clair M; Liao Q; McArthur JC
    Neurology; 2001 Oct; 57(8):1396-401. PubMed ID: 11673579
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rapid quantitative detection of Human immunodeficiency virus type 1 by a reverse transcription-loop-mediated isothermal amplification assay.
    Zeng Y; Zhang X; Nie K; Ding X; Ring BZ; Xu L; Dai L; Li X; Ren W; Shi L; Ma X
    Gene; 2014 May; 541(2):123-8. PubMed ID: 24630968
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.